Search

Your search keyword '"Faure, Christophe"' showing total 30 results
Start Over Author "Faure, Christophe" Journal journal of pediatric gastroenterology & nutrition
30 results on '"Faure, Christophe"'

1. Pediatric Aerodigestive Medicine: Advancing Collaborative Care for Children With Oropharyngeal Dysphagia

Author

Krasaelap, Amornluck, primary, Duncan, Daniel R., additional, Sabe, Ramy M. M., additional, Bhardwaj, Vrinda, additional, Lerner, Diana G., additional, Gold, Benjamin D., additional, Boesch, Richard Paul, additional, Faure, Christophe, additional, von Allmen, Daniel, additional, Williams, Dana, additional, Chiou, Eric, additional, DeBoer, Emily, additional, Hysinger, Erik, additional, Maybee, Jennifer, additional, Khlevner, Julie, additional, Larson, Kara, additional, Morris, Kimberly, additional, Jalali, Lauren, additional, McSweeney, Maireade, additional, Brigger, Matthew T., additional, Greifer, Melanie, additional, Rutter, Michael, additional, Williams, Nina, additional, Subramanyan, Ram Kumar, additional, Ryan, Matthew J., additional, Acra, Sari, additional, Pentiuk, Scott, additional, Friedlander, Joel, additional, Sobol, Steven E., additional, Kaul, Ajay, additional, Dorfman, Lev, additional, Darbari, Anil, additional, Prager, Jeremy D., additional, Rosen, Rachel, additional, Cocjin, Jose T., additional, and Mousa, Hayat, additional

Published
2023
Full Text
View/download PDF

6. Management of Gastroesophageal Reflux Disease in Esophageal Atresia Patients

Author

Lennep, Marinde, Gottrand, Frederic, Faure, Christophe, Omari, Taher I., Benninga, Marc A., Wijk, Michiel P., and Krishnan, Usha

Abstract

After surgical repair, up to 70% of esophageal atresia (EA) patients suffer from gastroesophageal reflux disease (GERD). The ESPGHAN/NASPGHAN guidelines on management of gastrointestinal complications in EA patients were published in 2016. Yet, the implementation of recommendations on GERD management remains poor. We aimed to assess GERD management in EA patients in more detail, to identify management inconsistencies, gaps in current knowledge, and future directions for research. A digital questionnaire on GERD management in EA patients was sent to all members of the ESPGHAN EA working group and members of the International network of esophageal atresia (INoEA). Forty responses were received. Thirty‐five (87.5%) clinicians routinely prescribed acid suppressive therapy for 1–24 (median 12) months. A fundoplication was considered by 90.0% of clinicians in case of refractory GERD with persistent symptoms despite maximal acid suppressive therapy and in 92.5% of clinicians in case of GERD with presence of esophagitis on EGD. Half of clinicians referred patients with recurrent strictures or dependence on transpyloric feeds. Up to 25.0% of clinicians also referred all long‐gap EA patients for fundoplication, those with long‐term need of acid suppressants, recurrent chest infections and feedings difficulties. Respondents’ opinions on the optimal duration for routine acid suppressive therapy and indications for fundoplication in EA patients varied widely. To improve evidence‐based care for EA patients, future prospective multicenter outcome studies should compare different diagnostic and treatment regimes for GERD in patients with EA. Complications of therapy should be one of the main outcome measures in such trials.

Published
2022
Full Text
View/download PDF

8. The Brussels Infant and Toddler Stool Scale: A Study on Interobserver Reliability

Author

Huysentruyt, Koen, primary, Koppen, Ilan, additional, Benninga, Marc, additional, Cattaert, Tom, additional, Cheng, Jiqiu, additional, De Geyter, Charlotte, additional, Faure, Christophe, additional, Gottrand, Frédéric, additional, Hegar, Badriul, additional, Hojsak, Iva, additional, Miqdady, Mohamad, additional, Osatakul, Seksit, additional, Ribes-Koninckx, Carmen, additional, Salvatore, Silvia, additional, Saps, Miguel, additional, Shamir, Raanan, additional, Staiano, Annamaria, additional, Szajewska, Hania, additional, Vieira, Mario, additional, and Vandenplas, Yvan, additional

Published
2019
Full Text
View/download PDF

11. Paediatric Intestinal Pseudo-obstruction: Evidence and Consensus-based Recommendations From an ESPGHAN-Led Expert Group

Author

Thapar, Nikhil, primary, Saliakellis, Efstratios, additional, Benninga, Marc A., additional, Borrelli, Osvaldo, additional, Curry, Joe, additional, Faure, Christophe, additional, De Giorgio, Roberto, additional, Gupte, Girish, additional, Knowles, Charles H., additional, Staiano, Annamaria, additional, Vandenplas, Yvan, additional, and Di Lorenzo, Carlo, additional

Published
2018
Full Text
View/download PDF

19. Esophageal Impedance Monitoring for Gastroesophageal Reflux

Author

Mousa, Hayat M, primary, Rosen, Rachel, additional, Woodley, Frederick W, additional, Orsi, Marina, additional, Armas, Daneila, additional, Faure, Christophe, additional, Fortunato, John, additional, O'Connor, Judith, additional, Skaggs, Beth, additional, and Nurko, Samuel, additional

Published
2011
Full Text
View/download PDF

27. Topical Mitomycin-C Application in Recurrent Esophageal Strictures After Surgical Repair of Esophageal Atresia

Author

Chapuy, Laurence, Pomerleau, Martine, and Faure, Christophe

Abstract

The aim of the present study was to evaluate the efficacy and short-term safety of topical mitomycin-C, an antifibrotic agent, in preventing the recurrence of anastomotic strictures after surgical repair of esophageal atresia (EA). We retrospectively reviewed the medical records of patients with recurrent anastomotic strictures after EA surgery who underwent at least 3 esophageal dilations. We compared the outcome (ie, resolution of the stricture) of the group that received topical mitomycin-C treatment with endoscopic esophageal dilation with a historical cohort treated by dilations alone. A total of 11 children received mitomycin-C concurrently with endoscopic dilations. After a median follow-up of 33 months (range 18–72), and a mean number of 5.4 dilations per patient (range 3–11), 8 of 11 patients achieved a resolution of their strictures, 2 patients remained with stenosis, and 1 patient needed a surgical correction. In the control group, 10 patients required an average of 3.7 (range 3–7) total dilations. After a follow-up of 125 months (range 35–266) after the last dilation, strictures in 9 of 10 children disappeared and the remaining patient was symptom free. No dysplasia related to mitomycin-C was demonstrated. There is no benefit in the resolution of the stricture when adding mitomycin-C treatment compared with repeated esophageal dilations alone in historical controls. Further randomized controlled studies and a short- and long-term evaluation of safety are needed.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results